Personal information

Emails & domains

Verified email domains

Other IDs

ResearcherID: G-7441-2017
Loop profile: 62501
Scopus Author ID: 21742412000
SciProfiles: 1133665

Countries

Switzerland

Activities

Collapse all

Employment (6)

Universität Zürich: Zurich, ZH, CH

Employment
Source: check_circle
University of Zurich

University Hospital of Lausanne: Lausanne, CH

2020-02-01 to present | Seniour Physician (Department of Dermatology)
Employment
Source: Self-asserted source
Emmanuella Guenova

University of Lausanne: Lausanne, VD, CH

2019-08-01 to present | Assoc. Professor (Faculty of Biology and Medicine)
Employment
Source: Self-asserted source
Emmanuella Guenova

University Hospital of Zurich: Zurich, CH

2013-03-01 to 2019-12-31 | Seniour physician-scientist (Department of Dermatology)
Employment
Source: Self-asserted source
Emmanuella Guenova

Harvard Medical School: Boston, MA, US

2011-07-01 to 2013-03-01 | Fellow (Brigham and Women’s Hospital)
Employment
Source: Self-asserted source
Emmanuella Guenova

Eberhard Karls Universität Tübingen: Tubingen, Baden-Württemberg, DE

2006-07-01 to 2011-06-01 | Resident in Dermatology (Department of Dermatology)
Employment
Source: Self-asserted source
Emmanuella Guenova

Education and qualifications (6)

University of Leipzig: Leipzig, Sachsen, DE

2014-09-01 to 2017-05-12 | M.Sc. Clinical Research and Translational Medicine (Clinical Trial Center (ZKS) )
Education
Source: Self-asserted source
Emmanuella Guenova

University of Zurich: Zurich, CH

2013-03-01 to 2015-12-17 | Priv.-Doz. (Venia Legendi für das Gebiet Dermatologie und Allergologie) (Faculty of Medicine)
Education
Source: Self-asserted source
Emmanuella Guenova

Harvard Medical School: Boston, MA, US

2011-09-16 to 2012-06-22 | Certificate in Applied Biostatistics (Harvard Catalyst’s Postgraduate Education Program in Clinical and Translational Science)
Education
Source: Self-asserted source
Emmanuella Guenova

Medical University Sofia: Sofia, BG

2007-09-15 to 2011-07-11 | PhD in Biochemistry (Department of Chemistry and Biochemistry)
Education
Source: Self-asserted source
Emmanuella Guenova

Eberhard Karls Universität Tübingen: Tubingen, Baden-Württemberg, DE

2003-09-01 to 2008-09-08 | Dr. med. (Department of Dermatology)
Education
Source: Self-asserted source
Emmanuella Guenova

Medical University of Sofia: Sofia, BG

1998-09-15 to 2003-06-15 | MD (Faculty of Medicine)
Education
Source: Self-asserted source
Emmanuella Guenova

Funding (14)

Targeting negative regulators of innate immunity to treat type 2-immune biased skin pathologies.

2024-10-01 to 2028-09-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.14357596
GRANT_NUMBER: 10003720
Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard

Systems medicine approach to tackle the problems of early diagnosing and prognostic stratification of mycosis fungoides

2021-09-01 to 2025-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.9772940
GRANT_NUMBER: 200253
Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard

Regulation of immune response by antigen-specific regulatory and effector memory B cells

2021-05-01 to 2025-04-30 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.9653463
GRANT_NUMBER: 201053
Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard

Defining tumour progression & immune modulation in the management of cutaneous T-cell lymphoma

2020-05-01 to 2024-04-30 | Grant
Krebsforschung Schweiz (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.13894314
GRANT_NUMBER:

KFS-4243-08-2017
Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard

Redirecting tumor-associated Th2 bias into an effective anti-tumor immunity by targeting the IL-4 – ATF3 loop in the cells of innate immunity

2020-01 to 2021-12 | Grant
European Academy of Dermatology and Venereology (Lugano, Europe, CH)
GRANT_NUMBER:

PPRC-2019-20
Source: Self-asserted source
Emmanuella Guenova

Brain cytochrome-c-oxidase assessed by NIRS as mitochondrial biomarker in depression

2019-06-01 to 2023-05-31 | Grant
Swiss National Science Foundation (Bern, CH)
URL: https://app.dimensions.ai/details/grant/grant.8483872
GRANT_NUMBER: 184755
Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard

Precision Hematology/Oncology

2019-01 to 2021-12 | Grant
Clinical Research Priority Program (CRPP) of the University of Zurich (Zurich, CH)
Part of GRANT_NUMBER: KFSP19
Source: Self-asserted source
Emmanuella Guenova

Deep learnig of cell morphology-based diagnosis of Sézary syndrome

2019-01 to 2020-12 | Grant
Personalized Health and Related Technologies (Zurich, CH)
URL: https://www.sfa-phrt.ch/
Part of GRANT_NUMBER:

PHRT-526
Source: Self-asserted source
Emmanuella Guenova

Studies on compound’s mode of action in cutaneous T cell lymphoma

2019-01 to 2020-12 | Grant
Helsinn Healthcare SA (Lugano, CH)
GRANT_NUMBER:

MCH1
Source: Self-asserted source
Emmanuella Guenova

Defining tumor progression & immune modulation in the management of cutaneous T-cell lymphoma

2018-05 to 2022-05 | Grant
Swiss Cancer Research (Bern, CH)
GRANT_NUMBER:

KFS-4243-08-2017

Source: Self-asserted source
Emmanuella Guenova

Computational prediction model for cancer progression based on single skin T cell RNA-sequencing of cutaneous lymphoma

2018-01 to 2021-12 | Grant
Promedica Stiftung (Zurich, CH)
GRANT_NUMBER:

1406/M

Source: Self-asserted source
Emmanuella Guenova

SCAI Dx Sézary

2018 to 2020 | Grant
Innosuisse Swiss Innovation Agency (Bern, CH)
GRANT_NUMBER:

30541.1 IP-LS

Source: Self-asserted source
Emmanuella Guenova
grade
Preferred source (of 2)‎

Impact of malignant T cells on innate and adaptive immune responses in cutaneous T cell lymphoma: blurring boundaries between immunodeficiency and cancer

Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard
grade
Preferred source (of 2)‎

Functional role of skin resident effector memory T cells in host protection against infections and behaviour in healthy skin and cutaneous lymphomas.

Source: Self-asserted source
Emmanuella Guenova via DimensionsWizard
How many people are using ORCID?